American Thoracic Society (ATS) Company Profile

Background

The American Thoracic Society (ATS), established in 1905 as the American Sanatorium Association, is a leading nonprofit organization dedicated to advancing global respiratory health through multidisciplinary collaboration, education, and advocacy. Originally focused on tuberculosis prevention and treatment, the Society evolved over the decades, adopting its current name in 1960 and becoming independently incorporated in 2000. With a membership exceeding 16,000 professionals worldwide, ATS plays a pivotal role in the fields of pulmonology, critical care, and sleep medicine.

Key Strategic Focus

ATS's strategic initiatives are organized into four main pillars:

1. Leading Scientific Discovery: Advancing research in respiratory science, including cellular and molecular biology, biochemistry, pharmacology, and lung physiology.

2. Transforming Patient Care: Setting high standards for respiratory care through clinical tools, practice guidelines, and best practices informed by the latest research.

3. Impacting Global Health: Driving positive change in public respiratory health on local, national, and global scales.

4. Advancing Professional Development: Providing educational programs and resources to support the growth of healthcare professionals in respiratory medicine.

These pillars guide ATS's efforts in research, education, and advocacy to improve respiratory health outcomes globally.

Financials and Funding

In the fiscal year ending December 2023, ATS reported:

Revenue: $35.8 million

Expenses: $34.9 million

Net Assets: $40.8 million

The organization's revenue streams include contributions, program services, investment income, and royalties. Notably, the ATS Research Program has awarded over $24 million in research grants since 2004, supporting more than 330 investigators who have collectively secured over $880 million in NIH funding.

Pipeline Development

While ATS is not a pharmaceutical company with a traditional product pipeline, it significantly contributes to the development of clinical practice guidelines and statements. To date, the Society has published more than 100 guidelines on topics ranging from pediatric asthma screening to the diagnosis and treatment of pneumonia and control of tuberculosis. These publications are instrumental in shaping patient care and treatment protocols worldwide.

Technological Platform and Innovation

ATS distinguishes itself through several proprietary initiatives:

Peer-Reviewed Journals: Publishing four esteemed journals—American Journal of Respiratory and Critical Care Medicine, American Journal of Respiratory Cell and Molecular Biology, Annals of the American Thoracic Society, and ATS Scholar—that disseminate groundbreaking research and clinical reviews.

Educational Platforms: Offering continuing medical education (CME) credits and maintenance of certification points through year-round learning programs and the annual International Conference, accessible via platforms like ATSEd+ and ATSConference365.

Research Grants: Providing substantial funding to early-career investigators, fostering innovation in pulmonary, critical care, and sleep medicine research.

Leadership Team

The ATS leadership comprises experienced professionals dedicated to advancing respiratory health:

President: Irina Petrache, MD, ATSF

President-Elect: Raed Dweik, MD, MBA, ATSF

Secretary: Michelle Ng Gong, MD, MS

Immediate-Past President: M. Patricia Rivera, MD, ATSF

Treasurer: Jesse Roman, MD, ATSF

Chief Executive Officer: Karen J. Collishaw, MPP, CAE

These leaders bring a wealth of experience in pulmonology, critical care, and organizational management, guiding ATS's strategic direction and operations.

Leadership Changes

In the 2024-2025 term, Dr. Irina Petrache assumed the role of President, succeeding Dr. M. Patricia Rivera. This transition reflects ATS's commitment to leadership continuity and its mission to advance respiratory health.

Competitor Profile

Market Insights and Dynamics

The respiratory health sector encompasses various organizations dedicated to pulmonology, critical care, and sleep medicine. Key players include:

American College of Chest Physicians (CHEST): Founded in 1935, CHEST focuses on chest medicine, including pulmonology, critical care, and sleep medicine, with a membership exceeding 19,000.

British Thoracic Society (BTS): Established in 1982, BTS aims to improve care for people with respiratory disorders in the UK, offering treatment guidelines and educational resources.

American Association for Respiratory Care (AARC): Founded in 1947, AARC supports respiratory care professionals in the U.S., promoting professional excellence and advancing the science and practice of respiratory care.

Competitor Analysis

While these organizations share similar goals, ATS differentiates itself through its comprehensive approach, encompassing leading scientific discovery, transforming patient care, impacting global health, and advancing professional development. Its extensive publication portfolio and robust research funding further enhance its standing in the respiratory health community.

Strategic Collaborations and Partnerships

ATS collaborates with various organizations to strengthen its impact:

International Partnerships: Engaging with global respiratory organizations like the European Respiratory Society and the Latin American Thoracic Society to promote respiratory health worldwide.

Public Advisory Roundtable (PAR): Incorporating patient and family perspectives into its initiatives, working with 15 member organizations representing individuals affected by pulmonary, critical care, and sleep problems.

Operational Insights

ATS's strategic focus on research, education, and advocacy positions it uniquely in the respiratory health sector. Its commitment to publishing high-quality research, providing educational resources, and funding innovative studies offers distinct competitive advantages over other organizations.

Strategic Opportunities and Future Directions

Looking ahead, ATS aims to:

Expand Global Reach: Enhance international collaborations to address respiratory health challenges worldwide.

Innovate Educational Offerings: Develop new educational programs and resources to meet the evolving needs of healthcare professionals.

Advance Research Initiatives: Increase funding and support for groundbreaking research in pulmonary, critical care, and sleep medicine.

By leveraging its strengths and embracing new opportunities, ATS is well-positioned to continue its leadership in advancing respiratory health globally.